JPSC:XETRA:XETRA-JPMorgan BetaBuilders US Small Cap Equity ETF USD Accumulation EUR (EUR)

ETF | Others |

Last Closing

USD 26.62

Change

0.00 (0.00)%

Market Cap

N/A

Volume

418.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.17 (-0.34%)

USD 502.95B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.35%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.10 (-0.36%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.07 (-0.23%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.08 (-0.33%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.14 (+0.82%)

USD 102.11B
JARI:XETRA Amundi Index Solutions - Amund..

-0.10 (-0.22%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.20 (-0.40%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+4.30 (+0.81%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.05 (-0.20%)

USD 79.79B

ETFs Containing JPSC:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.59% 52% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.59% 51% F 53% F
Trailing 12 Months  
Capital Gain 14.77% 66% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.77% 65% D 65% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.25% 56% F 55% F
Dividend Return 6.25% 55% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.11% 67% D+ 74% C
Risk Adjusted Return 77.13% 79% B- 82% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike